Skip to main content
. 2022 Oct 10;36:103224. doi: 10.1016/j.nicl.2022.103224

Table 2.

Contingency table presenting the number of participants from the NeuroPharm dataset in each of the treatment outcome groups.

Non-remitter Remitter Total
Non-responder 33 0 33
Responder 12 34 46
Total 45 34 79